Unfractionated and low-molecular-weight heparins in acute coronary syndromes: Current recommendations
Third in a series
Cleveland Clinic Journal of Medicine. 2000 January;67(1):59-65
January 1, 2000|Cleveland Clinic Journal of Medicine
Author and Disclosure Information
ABSTRACT
All patients with acute coronary syndromes and without obvious bleeding or acute cerebrovascular events are candidates for heparin therapy. This article is a review of the pharmacology of unfractionated and low-molecular-weight heparins, trials of heparin therapy in acute coronary syndromes, and recommendations for using these agents.
